Author
Listed:
- Shai Rosenberg
(Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, ICM
Sharett Institute for Oncology, Hadassah – Hebrew University Medical Center)
- Iva Simeonova
(Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, ICM)
- Franck Bielle
(Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, ICM
AP-HP, Hôpital de la Pitié-Salpêtrière)
- Maite Verreault
(Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, ICM)
- Bertille Bance
(Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, ICM)
- Isabelle Roux
(Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, ICM)
- Mailys Daniau
(Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, ICM)
- Arun Nadaradjane
(Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, ICM)
- Vincent Gleize
(Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, ICM)
- Sophie Paris
(Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, ICM)
- Yannick Marie
(Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, ICM
Institut du Cerveau et de la Moelle épinère—ICM)
- Marine Giry
(Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, ICM)
- Marc Polivka
(AP-HP, Hôpital Lariboisière)
- Dominique Figarella-Branger
(Assistance Publique-Hôpitaux de Marseille (AP-HM), CHU Timone)
- Marie-Hélène Aubriot-Lorton
(CHU Dijon Bourgogne)
- Chiara Villa
(Foch Hospital)
- Alexandre Vasiljevic
(Groupement Hospitalier Est, Hospices Civils de Lyon)
- Emmanuèle Lechapt-Zalcman
(CHU de Caen, Caen, France Normandie Univ, UNICAEN, CEA, CNRS, ISTCT/LDM-TEP Group)
- Michel Kalamarides
(Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, ICM
AP-HP, Hôpital de la Pitié-Salpêtrière)
- Ariane Sharif
(INSERM U1172, “Development and Plasticity of the Neuroendocrine Brain”)
- Karima Mokhtari
(Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, ICM
AP-HP, Hôpital de la Pitié-Salpêtrière)
- Stefano Maria Pagnotta
(Università degli Studi del Sannio
Columbia University Medical Center)
- Antonio Iavarone
(Columbia University Medical Center
Institute for Cancer Genetics, Irving Comprehensive Research Center)
- Anna Lasorella
(Columbia University Medical Center
Institute for Cancer Genetics, Irving Comprehensive Research Center)
- Emmanuelle Huillard
(Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, ICM)
- Marc Sanson
(Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, ICM
Institut du Cerveau et de la Moelle épinère—ICM
AP-HP, Hôpital de la Pitié-Salpêtrière
Site de Recherche Intégrée sur le Cancer (SiRIC) “CURAMUS”)
Abstract
Chordoid glioma (ChG) is a characteristic, slow growing, and well-circumscribed diencephalic tumor, whose mutational landscape is unknown. Here we report the analysis of 16 ChG by whole-exome and RNA-sequencing. We found that 15 ChG harbor the same PRKCA D463H mutation. PRKCA encodes the Protein kinase C (PKC) isozyme alpha (PKCα) and is mutated in a wide range of human cancers. However the hot spot PRKCA D463H mutation was not described in other tumors. PRKCA D463H is strongly associated with the activation of protein translation initiation (EIF2) pathway. PKCαD463H mRNA levels are more abundant than wild-type PKCα transcripts, while PKCαD463H is less stable than the PCKαWT protein. Compared to PCKαWT, the PKCαD463H protein is depleted from the cell membrane. The PKCαD463H mutant enhances proliferation of astrocytes and tanycytes, the cells of origin of ChG. In conclusion, our study identifies the hallmark mutation for chordoid gliomas and provides mechanistic insights on ChG oncogenesis.
Suggested Citation
Shai Rosenberg & Iva Simeonova & Franck Bielle & Maite Verreault & Bertille Bance & Isabelle Roux & Mailys Daniau & Arun Nadaradjane & Vincent Gleize & Sophie Paris & Yannick Marie & Marine Giry & Mar, 2018.
"A recurrent point mutation in PRKCA is a hallmark of chordoid gliomas,"
Nature Communications, Nature, vol. 9(1), pages 1-9, December.
Handle:
RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-04622-w
DOI: 10.1038/s41467-018-04622-w
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-04622-w. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.